Myomo (MYO) EBIT Margin (2016 - 2025)
Myomo posted quarterly EBIT Margin of 34.86% for Q3 2025, down 2446.0% year-on-year from 1.49% in Q3 2024, and up 26.7% on a QoQ basis from 47.56% in Q2 2025.
Myomo (MYO) has 10 years of EBIT Margin data on file, last reported at 34.86% in Q3 2025.
- For the quarter ending Q3 2025, EBIT Margin fell 2446.0% year-over-year to 34.86%; the trailing twelve-month figure through Sep 2025 stood at 28.51% (up 475.0% YoY), and the FY2024 full-year result was 19.07%, up 2371.0% from the prior year.
- EBIT Margin for Q3 2025 stood at 34.86%, up from 47.56% in the prior quarter.
- Across five years, EBIT Margin topped out at 2.03% in Q4 2024 and bottomed at 125.51% in Q1 2021.
- The 5-year median for EBIT Margin is 51.16% (2023), against an average of 54.45%.
- The widest annual swing landed in 2021, when EBIT Margin surged 24803 bps; it then tumbled 3273 bps in 2025.
- A 5-year view of EBIT Margin shows it stood at 67.11% in 2021, then climbed by 18 bps to 55.16% in 2022, then grew by 7 bps to 51.16% in 2023, then jumped by 96 bps to 2.03% in 2024, then tumbled by 1615 bps to 34.86% in 2025.
- The last three EBIT Margin figures came in at 34.86% (Q3 2025), 47.56% (Q2 2025), and 35.8% (Q1 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 12.05% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 15.55% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 16.24% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 21.16% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 28.97% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 6.17% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 21.42% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 10.04% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 19.94% |
| 10 | Myomo | 44.63 Mn | 26.23 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -34.86% |
| Jun 30, 2025 | -47.56% |
| Mar 31, 2025 | -35.80% |
| Dec 31, 2024 | -2.03% |
| Sep 30, 2024 | -10.40% |
| Jun 30, 2024 | -14.83% |
| Mar 31, 2024 | -103.58% |
| Dec 31, 2023 | -51.16% |
| Sep 30, 2023 | -39.85% |
| Jun 30, 2023 | -18.51% |
| Mar 31, 2023 | -77.49% |
| Dec 31, 2022 | -55.16% |
| Sep 30, 2022 | -71.03% |
| Jun 30, 2022 | -78.74% |
| Mar 31, 2022 | -70.81% |
| Dec 31, 2021 | -67.11% |
| Sep 30, 2021 | -46.31% |
| Jun 30, 2021 | -83.74% |
| Mar 31, 2021 | -125.51% |
| Dec 31, 2020 | -44.50% |
| Sep 30, 2020 | -132.10% |
| Jun 30, 2020 | -331.77% |
| Mar 31, 2020 | -339.48% |
| Dec 31, 2019 | -169.71% |
| Sep 30, 2019 | -465.70% |
| Jun 30, 2019 | -307.42% |
| Mar 31, 2019 | -323.20% |
| Dec 31, 2018 | -307.45% |
| Sep 30, 2018 | -444.75% |
| Jun 30, 2018 | -424.13% |
| Mar 31, 2018 | -767.26% |
| Dec 31, 2017 | -2,339.01% |
| Sep 30, 2017 | -293.73% |
| Jun 30, 2017 | -630.44% |
| Mar 31, 2017 | -7,371.29% |
| Dec 31, 2016 | -244.81% |
| Sep 30, 2016 | -506.98% |
| Jun 30, 2016 | -271.02% |